What Is MedVi? Understanding Telehealth Services and GLP-1

MEDVi has gained attention in the United States for offering telehealth services for online healthcare, particularly weight management programs involving GLP-1 medications. 

The platform connects users with licensed medical professionals without requiring consultations to take place in person.

MEDVi has also attracted attention because it uses AI in the development and operation of its business, including content creation and various digital processes. 

However, this use of AI should be distinguished from the medical process. MEDVi states that certain materials on its website may be created or enhanced using AI technology, while medical services are provided through a network of healthcare professionals and medical partners.

Key Takeaways

• MEDVi is a telehealth platform that focuses, among other things, on weight management and online access to GLP-1 treatments.
• AI is used in several aspects of MEDVi's business and content, but AI does not replace doctors in the prescription process.
• MEDVi programs are available on a cash-pay basis, while compounded GLP-1 medications have important differences from drugs approved by the FDA.

What Is MEDVi?

MEDVi is a telehealth platform that provides access to medical services online. One of its most well-known focuses is MEDVi weight loss, a weight management program that may include GLP-1 medications such as semaglutide and tirzepatide based on an evaluation by medical professionals.

According to official MEDVi information, medical services are provided through a network of medical providers and telehealth partners, including CareGLP Affiliated P.C.s and OpenLoop Health. MEDVi itself states that it is not a pharmacy and does not control third-party pharmacy services.

In addition to weight management, MEDVi also features other services such as men's health, women's health, peptide support, skincare, hair care, and nutritional support through MEDVi Meals.

This model means MEDVi is better understood as a digital healthcare services platform and a connector for medical services, rather than a replacement for doctors or hospitals.

Read Also: What Is RapidAI? An AI Medical Platform for Stroke Detection and Modern Imaging Analysis

How Does MEDVi Work?

MEDVi's process starts online. Users provide health information and treatment needs, which are then used as part of the medical evaluation process.

If the requirements are met, users may receive a consultation with a licensed medical professional. If a prescription is provided, it is then processed through the medical and pharmacy networks that work with the platform.

For GLP-1 programs, treatment options may include semaglutide and tirzepatide, either in compounded form or as certain branded medications. USA TODAY reported that MEDVi's program does not require insurance and uses a direct-payment model.

Therefore, MEDVi's process is not simply about buying medication online. There is still a screening and medical evaluation process before prescription medication is provided.

Start investing and trading AI tokens. Register on Bittime with a fast, secure, and easy process.

What Does MEDVi Use AI For?

One thing that distinguishes MEDVi from conventional telehealth services is its use of AI in building and operating its business.

A Business Insider report described MEDVi as a telehealth company that extensively uses AI in its business and marketing processes. 

MEDVi founder Matthew Gallagher also said that the company was built with an AI-first approach, although he denied that MEDVi is an AI company in the sense of a pure technology company.

On the other hand, MEDVi itself explicitly states that some text, images, and media materials on its website may be created or enhanced using AI technology. The website also explains that people appearing in advertising materials may be actors or models.

The important point is that AI should not be equated with an AI doctor. Official MEDVi information states that medical services continue to be provided by professionals and medical networks associated with the platform.

Read Also: Chinese Researchers Successfully Use AI in Medicine

What Is MEDVi GLP-1?

MEDVi GLP-1 refers to a weight management service that may use medications in the GLP-1 class. Two names that frequently appear are semaglutide and tirzepatide.

MEDVi offers compounded options as well as branded medications such as Wegovy and Ozempic, depending on availability and the results of the medical evaluation. 

Prices and medication options may change. In September 2026, USA TODAY reported that MEDVi's introductory price for compounded GLP-1 started at around US$179 for the first month, while subsequent prices varied depending on the type of medication and program.

However, readers should understand the difference between FDA-approved drugs and compounded medications. The FDA states that compounded drugs do not undergo the same FDA review process for safety, effectiveness, and quality before being marketed. 

The FDA also warns consumers not to consider compounded medications as generic versions or the same as drugs approved by the FDA.

Is MEDVi Free or Paid?

The question of whether MEDVi is free or paid has a fairly clear answer: this is not a free healthcare service.

MEDVi uses a direct-payment or cash-pay model and does not require users to have insurance. Costs depend on the medication, dosage, and program duration.

According to USA TODAY data from September 2026, compounded injectable semaglutide was offered starting at US$179 during the introductory period before moving to a regular price of around US$299 per month. 

Compounded tirzepatide was reported to start at around US$279 as an introductory price and then rise to around US$399 per month. Branded medications such as Ozempic and Wegovy are priced at higher levels.

Because prices and promotions may change, prospective users should check the latest costs before signing up.

Read Also: What Is CUDIS? The Wellness DePIN Token Turning Health Data into an Asset

Important Notes Before Using MEDVi

MEDVi and the telehealth GLP-1 industry in general have drawn attention from U.S. regulators regarding the marketing of compounded medications.

In March 2026, the FDA announced that it had sent 30 warning letters to telehealth companies regarding claims it considered false or misleading about compounded GLP-1 medications. 

The FDA emphasizes that compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or quality before being marketed.

MEDVi itself stated in April 2026 that the FDA letter mentioned in news reports was addressed to an affiliate marketing agency with a different website, not to MEDVi as a company. MEDVi said it had asked the affiliate to remove the materials in question.

Therefore, a MEDVi review should not only consider price or ease of registration. 

Users should also pay attention to who provides medical consultations, the source of the medication, the medication's approval status, dosage information, and support after the medication is received.

Don't miss AI coin price updates such as Bittensor (TAO), Venice Token (VVV), NEAR Protocol (NEAR), and Internet Computer (ICP) on Bittime.

Conclusion

What is MEDVi? MEDVi is a telehealth platform that connects users with online medical services, with a primary focus that includes weight management and access to GLP-1 treatments.

MEDVi uses AI in several business processes and content creation, but this does not mean prescriptions are issued by AI. Medical services still involve healthcare professionals and medical networks.

Inspired by the development of AI technology? It's time to monitor the movements of AI coins such as Bittensor (TAO), NEAR Protocol (NEAR), Artificial Superintelligence Alliance (FET), and Render (RENDER) on Bittime.

Bittime is a licensed Digital Financial Asset Trader (PAKD) platform supervised by the Financial Services Authority (OJK) — where you can buy Bitcoin in Indonesia and hundreds of other crypto assets starting from IDR 10,000. The registration process is fast, secure, and you can get started today.

Monitor the USDT to IDR conversion and real-time price movements of your favorite crypto assets. Everything is available in a single crypto investment app that can be downloaded for free from the Play Store.

Ready to get started? Register now on Bittime and execute your investment strategy with a platform trusted by millions of users in Indonesia.

FAQ

What Is MEDVi?

MEDVi is a telehealth platform that provides healthcare services online, including weight management programs that may involve GLP-1 medications.

Does MEDVi Use AI?

Media reports have documented the use of various AI tools in building and operating its business. However, AI does not replace medical professionals in the clinical process.

Does MEDVi Provide GLP-1?

Yes. MEDVi offers access to several GLP-1 options, including semaglutide and tirzepatide, as well as certain branded medications. Availability and prescriptions depend on medical evaluation.

Is MEDVi Free or Paid?

MEDVi is a paid service using a cash-pay model. Prices depend on the type of medication and program selected. Introductory prices for compounded GLP-1 were reported to start at around US$179 in September 2026.

Is Compounded GLP-1 the Same as FDA-Approved GLP-1 Medication?

No. The FDA states that compounded medications are not the same as generic drugs and do not undergo FDA review for safety, effectiveness, and quality before being marketed.

Can MEDVi Replace a Doctor?

No. MEDVi is a telehealth platform that facilitates medical services online. Decisions regarding diagnosis, treatment eligibility, and prescriptions still require authorized healthcare professionals.